Your session is about to expire
← Back to Search
Positional Therapy with LEFT Device for Acid Reflux
N/A
Waitlist Available
Led By Abdulfatah Issak, MD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients over the age of 18 who have proven GERD (with nighttime heartburn at least 3 days a week)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial will enroll 120 GERD patients who will be randomly assigned to either the intervention group or the control group. The intervention group will be asked to use the LEFT device for four weeks while the control group will be given general lifestyle and dietary recommendations.
Who is the study for?
This trial is for adults over 18 with proven GERD who experience nighttime heartburn at least three times a week. Participants must be able to read and complete questionnaires, have a compatible mobile phone, and agree to sleep positioning therapy using the LEFT device.Check my eligibility
What is being tested?
The study tests the LEFT device, an electronic wearable that trains patients to sleep on their left side using gentle vibrations. It aims to reduce nocturnal acid reflux symptoms in GERD patients by encouraging a specific sleeping position.See study design
What are the potential side effects?
Since the LEFT device uses noninvasive positional therapy through vibration, it's expected to have minimal side effects compared to medical treatments. However, discomfort from wearing the device or disturbances due to vibrations could occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 and have GERD with frequent nighttime heartburn.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The of the study is to determine if positional therapy, using the LEFT device, is effective in improving nighttime GERD-related symptoms as measured by GERD symptoms checklist (questionnaire, involves no specific units of measure).
Secondary outcome measures
The of the study is to determine if positional therapy improves quality of sleep and health-related quality of life as measured by Epworth Sleepiness, Scale and Sleep quality, SF-36 and Berlin questionnaires. No units of measure.
Trial Design
1Treatment groups
Experimental Treatment
Group I: LEFT Device ArmExperimental Treatment1 Intervention
Subjects in this arm will wear the LEFT device for 1 month
Find a Location
Who is running the clinical trial?
MetroHealth Medical CenterLead Sponsor
114 Previous Clinical Trials
21,374 Total Patients Enrolled
Abdulfatah Issak, MDPrincipal InvestigatorGastroenterology Fellow at Metrohealth MC
Ronnie Fass, MD5.02 ReviewsPrincipal Investigator - Director, Division of Gastroenterology and Hepatology at Metrohealth MC
MetroHealth Medical Center
10 Previous Clinical Trials
404 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I agree to follow sleep positioning therapy.I am over 18 and have GERD with frequent nighttime heartburn.I am under 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: LEFT Device Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger